发明名称 Selective beta 3 adrenergic agonists
摘要 The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formula II: The variables in Formula II are defined herein.
申请公布号 US6060492(A) 申请公布日期 2000.05.09
申请号 US19970882587 申请日期 1997.06.25
申请人 ELI LILLY AND COMPANY 发明人 BELL, MICHAEL GREGORY;CROWELL, THOMAS ALAN;MATTHEWS, DONALD PAUL;MCDONALD, III, JOHN HAMPTON;NEEL, DAVID ANDREW;SHUKER, ANTHONY JOHN;WINTER, MARK ALAN
分类号 A61K31/00;A61K31/40;A61K31/403;A61K31/404;A61K31/41;A61K31/415;A61K31/4164;A61K31/4184;A61K31/4192;A61K31/42;A61K31/423;A61K31/433;A61K31/44;A61K31/4427;A61K31/4433;A61K31/4439;A61K31/496;A61K31/50;A61K31/501;A61K31/53;A61K31/535;A61K31/5355;A61K31/537;A61K31/5375;A61K31/5377;A61P3/00;A61P3/10;A61P43/00;C07C235/46;C07C255/54;C07D209/08;C07D213/63;C07D235/06;C07D235/08;C07D235/26;C07D249/18;C07D257/04;C07D263/56;C07D263/58;C07D285/14;C07D295/18;C07D333/34;C07D401/12;C07D403/12;C07D409/12;C07D413/12;C07D417/12;(IPC1-7):A61K31/415 主分类号 A61K31/00
代理机构 代理人
主权项
地址